The board of directors biopharmaceutical company Merck (NYSE:MRK) declared a dividend of USD0.61 per share on the company's common stock for the second quarter of 2020, it disclosed on Tuesday.

This dividend is payable on 7 July 2020 to shareholders of record at the close of business as of 15 June 2020.

Merck said it continues to be at the forefront of research to prevent and treat diseases that threaten people and animals, including cancer, infectious diseases, HIV and Ebola, as well as emerging animal diseases.